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ABSTRACT
The existence of pockets of under-vaccinated persons has allowed outbreaks of disease in countries that 
have achieved high levels of vaccination coverage. A field-based methodology—GAPS (Geographic Assess-
ment of Planning and Services)—was developed to predict, in advance of an immunization campaign, the 
sites of which are most likely to have a pocket of unvaccinated persons and then use this information to 
improve planning, supervision, and evaluation of the campaign. At this time, there have been two applica-
tions of GAPS (Nepal and Ethiopia). The purpose of this paper was to evaluate these two applications of 
GAPS and make recommendations regarding its future use. Structured, expert interviews were conducted 
with at least three campaign organizers to evaluate each application of GAPS using purposive sampling.   
An evaluation of an individual campaign was considered positive when at least two of the three campaign 
organizers considered GAPS to be useful and worthwhile. The three campaign organizers interviewed fol-
lowing the GAPS application in Ethiopia responded that GAPS was useful and worth the effort. In Nepal, 
all four campaign organizers responded that GAPS was useful and worth the effort. Some suggestions for 
improvement were also identified. Although this evaluation was limited in the number of applications 
evaluated, GAPS appears to have promise as a practical method to help improve the quality of mass immu-
nization campaigns. And even if no pockets of unvaccinated persons are found, the method may serve as 
a rapid quality-check of administrative estimates of coverage. Further applications in different settings are 
needed to confirm these findings or under what circumstances GAPS might best be used.  GAPS may also 
be considered for improving other types of health campaigns, such as distribution of insecticide-treated 
bednets, vitamin A capsules, and deworming medications.   
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INTRODUCTION
Achieving a high percentage of vaccination cover-
age, while necessary, may not be sufficient for the 
elimination or eradication of disease. The existence 
of pockets of under-vaccinated persons has al-
lowed outbreaks of disease in countries that have 
achieved high levels of vaccination coverage (1-7).   
For this reason, information about coverage levels 
in the general population is not sufficient to de-
termine if a population is at risk of importation 
or continued transmission of disease. Information 
about whether or not pockets of under-vaccinated 
persons exist would also help understand the risks 
of disease transmission.
Weiss et al. identified factors that predict whether or 
not a child will receive vaccine during a mass cam-
paign (8). These factors can help us predict and/or 
identify the existence of pockets of susceptible 
children. For example, if one or more predictive 
factors are geographically clustered, the population 
living in this geographic cluster is at risk of having 
a pocket of unvaccinated persons. We can use this 
information before, during, and after the campaign 
to help us take steps to prevent and/or address the 
development of a pocket of unvaccinated persons.Weiss WM et al. Use of GAPS in improving quality of mass immunization campaigns
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A way to predict likely geographic clusters of unvac-
cinated persons may be useful when planning, su-
pervising, and evaluating mass campaigns (8). With 
this information, priority can be given to assess the 
quality of planning for such sites. Priority can also 
be given to supervision and post-campaign evalua-
tion of these sites. If indicated, steps can be taken 
to prevent problems that may lead to geographic 
clusters of unvaccinated, or to address any prob-
lems identified. This paper describes an evaluation 
of the experience to date with one such field-based 
methodology, which we call GAPS (Geographic As-
sessment of Planning and Services) in two settings 
(Ethiopia and Nepal). Before presenting the evalua-
tion, a brief description of GAPS is provided below 
[The GAPS manual with the questionnaire and in-
terview guides and instructions, and more detailed 
reports of the two applications of GAPS are avail-
able from the authors].
Description of GAPS
We carry out GAPS before, during, and immedi-
ately after a mass vaccination campaign. Following 
this pattern, GAPS has three phases: (a) improve 
planning before the campaign begins, (b) improve 
implementation/monitoring of the campaign, and 
(c) carry out the post-campaign evaluation and fol-
low-up.  We describe below the action-steps we take 
in each phase.
GAPS Phase 1: Improve planning before the 
campaign begins
As a first step during Phase 1, we identify a geo-
graphic area—usually a district or province that 
will participate in a mass vaccination campaign. 
The second step is to identify sites within that area 
that warrant special attention through expert in-
terviews. The interview format is semi-structured 
that follows a guide available in the manual. Dur-
ing the interview, local experts are asked if certain 
factors—those identified during the past studies as 
factors that predict missed vaccination in mass im-
munization campaigns (8)—are clustered in any 
sites within the area. Sites mentioned several times 
by each expert during the interview are selected as 
geographic areas that warrant special attention (a 
form of triangulation). The third step is to review 
campaign plans for the sites selected for special at-
tention. The fourth and final step is to address any 
gaps identified in the campaign plan for sites we 
have designated as high-priority.  In our actions, we 
are limited to solutions that can be carried out with 
available resources; these resources may come from 
government, UN agencies, health programmes 
of non-governmental organizations (NGOs), or 
community-based organizations. For example, if 
there is a gap in social mobilization activities in a 
site, an NGO might conduct a community meet-
ing or other health-promotion activities, such as 
a skit, rally, or parade. By these actions, before the 
campaign begins, we may prevent problems in the 
campaign.
GAPS Phase 2: Improve implementation and 
monitoring of the campaign
During this phase of GAPS, the first step is to de-
cide—from information gathered during Phase 
I—which sites will be given priority attention for 
supervision during the campaign, given available 
resources for supervision (time, vehicles, and num-
ber of persons). For example, if available resources 
only allow supervision-visits to five sites, we decide 
what we believe to be the first five sites we should 
visit in order of priority. The second step is to iden-
tify if there are any problems in implementing 
the campaign that may result in a site having a 
pocket of unvaccinated persons. Using a supervi-
sion checklist (usually one that is in use nationally, 
although an example is provided in the manual), 
we observe immunizations provided at any fixed 
posts and by house-to-house vaccination teams 
within the sites we supervise. During supervision, 
we observe the quality of vaccine, equipment, and 
supplies and assess knowledge and practices of 
vaccinators using a convenience sample. We also 
visit homes in a site using a convenience sample 
to check the vaccination status of persons in these 
homes and inquire about reasons for any missed 
vaccination. A convenience sample is used for al-
lowing more vaccination sites and homes to be visi-
ted and allowing for more flexibility in follow-up 
of problems identified than a more structured 
sampling method would allow. The third and final 
step of GAPS Phase 2 is participation in quality-
improvement activities, as indicated by findings of 
supervision, to prevent or address problems before 
the end of the campaign. We present our findings to 
organizers of the campaign (e.g. district health offi-
cer, district immunization programme manager, im-
munization officers of World Health Organization 
[WHO]  or  United  Nations  Children’s  Fund  [UNI-
CEF]) and then participate with them in follow-up 
actions depending on available resources.
GAPS Phase 3: Carry out the post-campaign 
evaluation and follow up
The first step in GAPS Phase 3 is to decide what sites 
will be visited during the post-campaign evalua-Weiss WM et al. Use of GAPS in improving quality of mass immunization campaigns
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tion. This decision is based partly on observations 
of the campaign by GAPS participants and cam-
paign officials, partly on discussions with cam-
paign organizers prior to the campaign, and partly 
on resources (manpower, time, money) available. 
Therefore, the list of sites we decide to visit during 
Phase 3 may be a mix of sites; some that we sus-
pected even before the campaign as likely to have 
problems, and some where problems were identi-
fied only during observations of the campaign. 
The second step is to design a hypothesis test of 
the post-campaign evaluation. The hypothesis is 
that the campaign coverage in a site to be evalu-
ated is unacceptable because the site has a pocket 
of unvaccinated persons (defined as 20% or more 
of the target population unvaccinated in that site). 
The null hypothesis is that the campaign coverage 
in the site is acceptable because the site does not 
have a pocket of unvaccinated children. We used 
lot quality assurance sampling (LQAS) techniques 
to classify whether or not the campaign coverage 
in a site is acceptable or not (9,10). In contrast to 
more typical uses of LQAS to assess the vaccination 
coverage in a larger geographic area, LQAS is used 
here for testing a hypothesis that a site has a cluster 
of unvaccinated children (11). The following LQAS 
design was used in each application evaluated in 
this paper (9-12): (a) Target value of 80% with a 
specificity greater than 90% (this also is the upper 
threshold); (b) Lower threshold of 50%, with a sen-
sitivity greater than 90%; (c) Random sample size 
of 19 households, with one or more children aged 
less than five years; and (d) Decision rule of 13.
The expected coverage of a mass immunization 
campaign for polio is close to 100% (13-19). Giv-
en this, we recommend a target value of 80%. We 
considered 80% sufficiently lower than the typical 
coverage achievement as to warrant special action 
and resources to improve the coverage in any site 
found to be below the target. The unit of analysis 
was a lot of 19 randomly-selected households, with 
a child aged less than five years in each site. If less 
than 13 of the 19 households have all children 
aged less than five years vaccinated, the coverage 
is classified as unacceptable, the null hypothesis is 
rejected, and the evaluation site is judged as hav-
ing a pocket of unvaccinated persons. Conversely, 
if 13 or more households have all children aged less 
than five years vaccinated, the coverage is classified 
as acceptable, the null hypothesis is not rejected, 
and the evaluation site is considered NOT to have a 
pocket of unvaccinated children.  
The third step in GAPS Phase 3 is to carry out the 
hypothesis testing in sites selected. We select each 
household at random according to the process des-
cribed by Valadez et al. (10). In each household se-
lected, we interviewed caretakers of children aged 
less than five years. During the interview, we iden-
tified the vaccination status of each child aged less 
than five years in the household. We also identi-
fied any self-reported reasons for why a child was 
missed being vaccinated, if indicated. The final 
step of GAPS Phase 3 is to participate in quality-
improvement activities as indicated by the find-
ings of the post-campaign evaluation. We present 
the evaluation information—about successes and 
problems and main causes of problems—to orga-
nizers of the campaign (e.g. district health officer, 
district immunization programme manager, WHO 
or UNICEF immunization officers). We then partici- 
pate in discussions with them about what can be 
done—with available or obtainable resources—to 
correct any deficiencies identified (and who would 
be responsible for these corrective actions). Follow-
ing these discussions, we participate in quality- 
improvement activities to address problems before 
the next campaign as indicated by the discussions 
mentioned above.
GAPS is one of several rapid assessment methods 
that have been developed to identify clustering or 
pockets of health problems in a quick, simple and 
inexpensive way. Rapid assessments have been de-
veloped to assess elimination of neonatal tetanus, 
the pattern and severity of trachoma, the ende-
micity of onchocerciasis, and other health prob-
lems (20-33). All these methods, including GAPS, 
include some method for deciding with sites that 
are at an increased risk of having a health problem 
and, therefore, deserve priority attention for study 
(and action if a problem is confirmed). GAPS is dis-
tinct from these because it seeks to prevent health 
problems, not simply to address them once identi-
fied. GAPS typically uses smaller sample sizes than 
these other rapid assessment methods. Alternative 
methods of assessment typically include prevalence 
surveys that are costly and require more time.
GAPS experience to date
At this time, there have been two complete applica-
tions of GAPS to date: (a) in one  woreda (district) in 
the Southern Nations Region of Ethiopia and (b) 
in one terai district in Nepal that shares a border 
with India [Detailed reports of these applications 
are  available  from  the  authors].  Both  the  appli-
cations of GAPS in this paper were carried out at 
the district level for improving the quality of mass 
polio-vaccination campaigns, although GAPS can 
be used for other types of campaigns (vaccine, vita-Weiss WM et al. Use of GAPS in improving quality of mass immunization campaigns
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min A, bednets). In both the applications, teams 
comprising district-level representatives from gov-
ernmental and non-governmental organizations 
worked together to carry out the GAPS process. 
These representatives easily learned and applied 
the  GAPS  methodology  within  their  own  work- 
settings to improve an activity they were responsible 
for organizing and/or supporting. In both the set-
tings, we observed some procedural problems, with 
little indication that more than just a few children 
were being missed and no indication of pockets of 
unvaccinated children. These were our findings, 
although we assessed sites considered by local ex-
perts (government and NGOs) to be the most likely 
sites in our districts to have problems.  Mass immu-
nization campaigns that achieve a high coverage 
and do not leave pockets of unvaccinated persons 
are important for interrupting the transmission of 
disease. This is probably one explanation for why 
Ethiopia and Nepal have had a few reported wild 
polio cases since 2000/2001, although cases have 
been reported along the border of these countries 
in subsequent years.  
Since the GAPS process is flexible and since the 
process can be adapted to match the availability of 
local resources, there were differences between the 
two applications reported here. In the Nepal appli-
cation, the investigator applied GAPS in a district 
where an NGO was receiving project funds from 
the United States Agency for International Deve-
lopment (USAID), Washington, DC to support the 
Government’s polio- eradication efforts (mass cam-
paigns, surveillance, etc.). In Nepal, the NGO had 
dedicated staff for this effort at the district level and 
resources for a vehicle and had hired independent 
monitors (in addition to the investigator). In Ethio-
pia, GAPS was carried out in a district where no 
NGO was receiving project funds to support polio-
eradication efforts. In this zone, NGOs did support 
the government polio-eradication efforts but not 
with specific project funds. The campaign in Nepal 
was implemented on two days (Saturday and Sun-
day) whereas the campaign in Ethiopia was carried 
out over seven days due to terrain and the layout of 
households within communities. In Nepal, district 
health staff involved in the GAPS application had 
access to vehicles whereas, in Ethiopia, the district 
health staff relied on the investigators’ vehicle to 
participate. The implication of these differences 
was that more resources were available on a daily 
basis in Nepal compared to Ethiopia, and require-
ments of resources were higher in Ethiopia. Typi-
cally—during the campaign and post-campaign 
evaluation—we were able to visit many sites each 
day in Nepal but only one site per day in Ethiopia. 
It was also more difficult for staff to participate in 
the GAPS application in Ethiopia compared to Ne-
pal because the campaign lasted for five days more 
than the Nepal campaign. More persons participat-
ed in Nepal—some coming from government and 
UN offices in Kathmandu—because it was easier to 
find the time to participate. One effect of the differ-
ences mentioned above is that we were only able 
to carry out the post-campaign evaluation in one 
site in Ethiopia.
Following these two applications of GAPS, several 
questions remained to be answered, among others. 
First, does GAPS accomplish the objectives it was 
designed to produce? Second, are there any sug-
gestions for the improvement of the GAPS metho-
dology? This paper describes an evaluation of the 
current experiences with GAPS to date to answer 
these two questions. In the following section, we 
describe the evaluation methodology. Then, the 
results and conclusions of the evaluation—about 
GAPS—are provided.
MATERIALS AND METHODS
The evaluation of GAPS described below assessed 
how GAPS was used and thought about by per-
sons who were involved in organizing or evaluat-
ing the two mass polio campaigns at the national 
and local levels (herein called campaign organiz-
ers). The long-term utility of GAPS in any site will 
be determined by campaign organizers’ beliefs 
about the method and how these persons use the 
information generated by GAPS. Specifically, we 
purposively sampled government, NGO and UN 
representatives to participate in the evaluation to 
provide both a district/operational-level perspec-
tive and a national-level perspective. At the district 
level, the district EPI manager or his/her assistant is 
typically responsible for evaluating the campaign. 
In addition, surveillance officers of WHO or pro-
gramme officers of NGOs working in the district 
may be supporting the organization and evalua-
tion of the campaign. We consider these persons 
to be campaign organizers at the local level. At the 
national level, there is usually someone working 
in the immunization programme or child health 
programme of the Ministry of Health, who is res-
ponsible for organizing and analyzing routine 
evaluation data about the campaign.  Alternatively, 
there are often one or more persons at the WHO or 
UNICEF, who help the Government organize and 
evaluate national immunization campaigns. We 
consider these persons to be campaign organizers 
at the national level.Weiss WM et al. Use of GAPS in improving quality of mass immunization campaigns
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The evaluation of GAPS described here assessed 
only short-term outcomes, such as reactions to the 
method and immediate use of information that 
GAPS provides. It would be ideal to look at sustain-
ability of the method several years after its intro-
duction in a country and/or district. However, this 
was considered to be impractical due to the time 
required and the time limits of this research.  To 
evaluate GAPS, the experience of GAPS in two sepa-
rate campaigns was assessed. If the first two evalua-
tions were not similarly positive, a third evaluation 
(in a different campaign and site) would have been 
carried out. For the purposes of this evaluation, we 
considered GAPS to have successfully accomplished 
its objectives if the evaluation of at least two cam-
paigns demonstrated positive results.
The evaluation of each individual campaign was 
carried out using semi-structured, expert interviews 
with at least three campaign organizers who were 
purposively sampled. We tried to interview respon-
dents so that we have a mix of NGO, government 
and UN backgrounds and district-level and nation-
al-level experience [A GAPS manual that includes 
instructions and data-collection instruments is 
available from the authors]. An evaluation of an in-
dividual campaign was considered positive when 
the responses of at least two of the three campaign 
organizers were consistent with expected outcomes 
detailed as follows: 
1. In cases where GAPS identified at least one geo-
graphic area as having many unvaccinated chil-
dren, at least two of three campaign organizers:
a. stated that they agree that GAPS is useful 
for identifying geographic areas requiring 
special immunization attention; 
b. recommended that the problems identified by 
GAPS be addressed (or stated that they have 
already decided to do so); and
c. stated that carrying out GAPS was worth the 
effort.
2. In cases where GAPS did not identify at least one 
geographic area as having a few or zero unvac-
cinated children, at least two of three campaign 
organizers:
a. stated that they agree that GAPS is useful for 
confirming the effectiveness of campaign 
planning and implementation in such areas 
(or stated that GAPS is useful for compar-
ing with routine information collected during 
campaigns);
b. recommended continuing the current cam-
paign strategies (or stated that they have al-
ready decided to do so); and
c. stated that carrying out GAPS was worth 
the effort. 
A semi-structured questionnaire developed for each 
of the two cases described above included close-
ended and open-ended questions, such as recom-
mendations for improving the method or explana-
tions of responses to close-ended questions [This 
and other sets of questionnaire are included in the 
manual available from the authors]. The close-
ended questions are tallied by hand for analysis of 
frequency distributions. The open-ended questions 
were read for understanding better the responses 
to the close-ended questions and learning what 
suggestions of the respondents for improving the 
method were.
Ethics
The GAPS application and evaluation methodolo-
gy was reviewed and given a certificate of exemp-
tion by the Johns Hopkins Bloomberg School of 
Public Health, Committees on Human Research 
under no. 45 CFR 46.101. No identifiers were col-
lected during interviews with experts or household 
members. Letters of collaboration from local NGOs 
and ministries of health were obtained instead of 
local IRB approval since the evaluation involved as-
sessing quality-improvement efforts of an ongoing 
government health intervention (in this case, mass 
immunization campaigns to eradicate polio).
RESULTS
We evaluated two applications of GAPS within one 
week following each application. The first applica-
tion was in Ethiopia and the second one in Nepal.   
The results of each evaluation of GAPS are present-
ed below in turn beginning with Ethiopia.
First application of GAPS in Sidama zone, 
Ethiopia, by phase 1-3
During  13-28  October  2003,  the  first-ever  ap-
plication of GAPS was conducted around a Sub- 
national Immunization Day (SNID) in Sidama 
zone, Southern Nations Region, Ethiopia. The date 
of this SNID was 17-23 October [A description of 
the GAPS method and results for this application 
are available from the authors]. Of major impor-
tance is that this GAPS application did not identify 
any  pockets  of  unvaccinated  children  following 
the SNID. The evaluation of this GAPS application 
is described below.Weiss WM et al. Use of GAPS in improving quality of mass immunization campaigns
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We carried out expert interviews with a purposive 
sample  of  three  persons.  The  GAPS  evalua-
tion form we used and tailored—for a situation 
where no evaluation sites failed the post-campaign 
evaluation—is provided in the GAPS manual. The 
first person we interviewed was the health coordi-
nator who provided technical backstopping to the 
only NGO health programme that was supporting 
(voluntarily) the immunization campaign in the 
district in which we carried out GAPS. This respon-
dent provides technical backstopping to several 
health programmes located in the southern region 
of Ethiopia, including the district in Sidama zone 
where we had carried out the first GAPS applica-
tion. Earlier, this respondent participated as a team 
member during the GAPS application and was able 
to observe the process and discuss the results first 
hand. This respondent was selected for an expert 
interview because we felt that he was the only per-
son who could bring an NGO perspective at an 
operational level, who had experience with evalu-
ating and supporting vaccination campaigns, and 
who was very knowledgeable about GAPS due to 
his participation on the GAPS team in this very ap-
plication
The second person we interviewed was a health 
official for the district/woreda where the first GAPS 
application was carried out. This respondent has 
major oversight responsibilities for the vaccination 
programme in the woreda, and he was intimately 
involved in planning, implementation, and evalu-
ation of the SNID in this district. This respondent 
also participated as a team member during the GAPS 
application in his district. We selected this person 
for an expert interview because he was the only 
person who could bring a government perspective, 
who had experience in evaluating and supporting 
vaccination campaigns at an operational level, and 
who was also very knowledgeable about GAPS due 
to his/her participation on the GAPS team.  
The third person interviewed was a health officer 
for a UN agency with substantial responsibility for 
supporting the planning, implementation, and 
evaluation of vaccination programmes and other 
child-health programmes. This respondent pri-
marily provides technical support to government 
child-health programmes and is a technical officer 
of her agency. This respondent did not participate 
as a GAPS team member in Sidama zone. She did at-
tend both pre- and post-campaign orientations and 
debrief on the GAPS application, however, before 
the interview. We selected this person for an expert 
interview because she could bring a UN agency- 
and national-level perspective, was experienced 
with many types of evaluations, would have re-
sponsibility for supporting future vaccination 
campaigns, was fairly knowledgeable about GAPS 
due to her participation in pre- and post-GAPS ori-
entations, and expressed interest in the methodo- 
logy during both the orientations. All the three 
respondents have experience or responsibilities 
with vaccination programmes, with evaluations, 
and with GAPS (at a minimum they experienced 
a detailed orientation about GAPS). In addition, 
both national-level and operational-level perspec-
tives are included, as are NGO, government, and 
UN perspectives, as designed.
A summary of the results of the Ethiopia GAPS 
evaluation is provided in Table 1. We consider 
the results of this evaluation positive due to the 
following: (a) all the three evaluators agreed that 
GAPS is useful for confirming the effectiveness of 
campaign planning and implementation in areas 
where a few or no children were missed by the 
vaccinators; (b) two of the three recommended 
continuing the current campaign strategies in 
those areas; and (c) when asked if carrying out 
GAPS was worth the effort, all the three respon-
dents said ‘yes’. When asked an open-ended ques-
tion to explain their responses, we received the 
following replies:
(GAPS) provided skills to monitor activities …. 
We can see the quality of health services (Gov-
ernment, district-level respondent).
The GAPS experience provided knowledge and 
skills … to find the effectiveness of some pro-
grammes (NGO, district-level respondent).
(GAPS) is cost-effective time-wise and practical 
… it is an effective rapid assessment (UN, na-
tional-level respondent).
In sum, the respondents provided responses about 
GAPS that are consistent with its design for use and 
follow-up action. The respondents also mentioned 
several barriers to implementation, although no 
two respondents mentioned the same thing: one 
respondent stated that staff turnover requires con-
tinuous access to training in such a methodology, 
and another respondent mentioned that there 
was a need for policy change to support the use of 
such techniques. Another limitation of GAPS men-
tioned by a respondent was that GAPS can identify 
problems but may not provide sufficient informa-
tion by itself to understand the causes of problems 
identified.Weiss WM et al. Use of GAPS in improving quality of mass immunization campaigns
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Second application of GAPS in Dhanusa 
district, Nepal, by phase 1-3
During 18-27 February 2004, we carried out the sec-
ond application of GAPS during a National Immu-
nization Day (NID) in a terai district of Nepal; terai 
districts border India with endemic transmission 
of wild poliovirus just kilometres from the border.   
The date of this NID was 21 and 22 February [A des-
cription of this GAPS application is available from 
the authors]. Similar to the findings of the GAPS 
application in Ethiopia, this GAPS application also 
did not identify any pockets of unvaccinated chil-
dren remaining following the NID. The evaluation 
of this GAPS application is described below.
We carried out expert interviews with four persons 
using a purposive sampling process. Similar to the 
Ethiopia GAPS application, the GAPS evaluation 
form we used was for a situation where no evalua-
tion sites failed the post-campaign evaluation. The 
first person we interviewed was a health official for 
the district where this GAPS application was carried 
out. This respondent has major oversight responsi-
bilities for the vaccination programme in the dis-
trict, and he was intimately involved in planning, 
implementation, and evaluation of the NID in the 
district. This respondent also participated as a team 
member during the GAPS application in his dis-
trict. We selected this person for an expert inter-
view because he was the only person who could 
bring a local-government perspective, who had 
experience in evaluating and supporting vaccina-
tion campaigns at an operational level, and who 
was also very knowledgeable about GAPS due to his 
participation in the GAPS team.
The second person we interviewed was the project 
manager of an NGO health programme office in 
the district where we applied GAPS methodology. 
This respondent managed and provided technical 
backstopping to several health programmes lo-
Table 1. Results of evaluation of GAPS, Ethiopia, October 2003
Name of campaign SNID Sidama zone, Ethiopia
No. of evaluation sites 1
No. passed/no. failed 1  /  0
Campaign organizer/respondent 1 2 3
Summary
calculations
Level of responsibility District District National
Type of organization  NGO Government UN/WHO
State that GAPS is useful for confirming 
the effectiveness of campaign planning 
and implementation
(and/or state that GAPS is useful for 
comparing with routine information 
collected during campaigns)
Yes Yes Yes Yes–3  
 No–0
State that they recommend (or have 
already decided) continuing campaign 
strategies
No Yes Yes Yes–2
No–1
State that carrying out GAPS was worth 
the effort
Yes Yes Yes Yes–3
No–0
Most frequently-mentioned negative 
things about GAPS
No. Idea Frequency
1 Staff turnover requires continued 
access to training opportunities
1
2 Need for policy change to support 
use of such techniques
1
3 Does not provide the cause of 
problems identified
1
Most  frequently-mentioned  ideas  for 
making the evaluation more useful or 
practical
None 
 
NA 
 
GAPS=Geographic assessment of planning and services; NA=Not applicable; NGO=Non-governmental 
organization; SNID=Sub-National Immunization Day; UN=United Nations; WHO=World Health Or-
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cated in the district, including a polio-eradication 
project. Earlier, this respondent participated as a 
team member during the GAPS application and 
was able to observe the process and discuss the re-
sults first hand. This respondent was selected for an 
expert interview because he was the only person 
who could bring an NGO perspective at an opera-
tional level, who had experience with evaluating 
and supporting vaccination campaigns, and who 
was very knowledgeable about GAPS due to his par-
ticipation in the GAPS team.
Our third interview was with a high-level health of-
ficial of the Government of Nepal. This person had 
a leading responsibility for supporting the plan-
ning, implementation, and evaluation of all vacci-
nation programmes in Nepal. This respondent also 
participated as a GAPS team member in this terai 
district. We selected this person for an expert in-
terview because he was the only person who could 
bring a national-level government perspective, 
who was responsible for helping make major deci-
sions about the vaccination programme in Nepal, 
who would have responsibility for organizing fu-
ture vaccination campaigns, who was experienced 
with many types of evaluations, and who was very 
knowledgeable about GAPS due to his participation 
in this GAPS application. 
The fourth person interviewed was a health officer 
for a UN agency with substantial responsibility for 
supporting the planning, implementation, and 
evaluation of vaccination programmes in Nepal. 
This respondent primarily provides technical sup-
port to government vaccine programmes and is a 
technical officer of his/her agency. This respondent 
also participated as a GAPS team member in this te-
rai district. We selected this person for an expert in-
terview because he was the only person who could 
bring a UN agency- and national-level perspective, 
who was experienced with many types of evalu-
ations, would have responsibility for supporting 
future vaccination campaigns, and who was very 
knowledgeable about GAPS due to his participa-
tion in this GAPS application. All the four res-
pondents have experience or responsibilities with 
vaccination programmes, with evaluations, and 
with GAPS. As per the study design, we obtained 
the perspectives of persons working at both nation-
allevel and operational level and persons work-
ing with an NGO, the government, and the UN.
The results of the Nepal GAPS evaluation are pre-
sented in Table 2. We consider the results of this 
second evaluation positive for the same reasons as 
described above in the Ethiopia application. When 
respondents were asked to explain their positive 
evaluation of GAPS, we received the following re-
plies:
(GAPS provided) more return than investment 
… We are now more confident that the strat-
egy worked, and the coverage was high … and 
we also have information about process prob-
lems  that  can  be  addressed  (a  government, 
district-level respondent).
Because the cost of not finding an existing pock-
et may be higher (an NGO, district-level respon-
dent).
The resources spent have a positive result which 
is a value … (the process) also gives the com-
munity awareness of the importance of vacci-
nation, an appreciation of our interest in what 
happens there (a government, national-level 
respondent).
A minimum of time was needed to do this (a 
UN, national-level respondent).
As with the Ethiopia application, the responses 
provided by the Nepali respondents are consistent 
with the purpose of GAPS. The respondents also 
mentioned one limitation: due to resource con-
straints, it is not possible to visit each potential 
problem site for a post-campaign evaluation. Two 
primary suggestions for the improvement of the 
GAPS methodology were provided: (a) adapt ele-
ments of the GAPS methodology for other vaccina-
tion programme activities and (b) during the post-
campaign evaluation, visit potential problem sites 
that were never visited during the campaign or just 
prior (overcome any possible ‘Hawthorne’ effect of 
the attention sites receive because of GAPS).
DISCUSSION 
The respondents participating in the evaluation of 
GAPS stated that GAPS was useful for confirming 
the administrative estimates of campaign cover-
age, indicating that the campaigns were effectively 
planned and implemented. These responses are 
consistent with the design of GAPS in the situation 
where no pockets of unvaccinated children were 
found—the case in both the applications in Ethio-
pia and Nepal. This is one important additional 
value of GAPS—a rapid method for checking the 
quality of mass campaigns rather than relying on 
administrative estimates of coverage alone. Admin-
istrative estimates of coverage are based on dividing 
the number of persons vaccinated by the number 
of persons in the target group (e.g. children aged Weiss WM et al. Use of GAPS in improving quality of mass immunization campaigns
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less than five years)—a number obtained from a 
census that may be old and/or poorly implemented 
leading to greater than 100% coverage when under- 
estimated. By systematically including GAPS (or 
at minimum the final post-campaign evaluation 
phase of GAPS) in mass campaigns, campaign orga-
nizers are able to compare administrative estimates 
of coverage with another population-based source 
of data.
Similar to other rapid assessment methods, particu-
larly those designed to identify pockets of disease, 
GAPS is designed to test hypotheses about cluster-
ing or pockets of health problems in a relatively-
rapid, simple, and inexpensive way. Each of these 
methods has a process for deciding with sites that 
are at an increased risk of having a health problem 
and, therefore, deserve priority attention for super-
vision (and action if a problem is confirmed). In 
contrast to these other methods, GAPS requires a 
smaller sample size that may lead to less time and 
cost to carry out. This suggests that it may be fea-
sible for managers of mass campaigns to use GAPS 
routinely to improve the planning, implementa-
tion, and evaluation of the campaigns. In addi-
tion, GAPS seeks to prevent health problems before 
they occur by improving planning and to identify 
problems that may be addressed before the end of 
a campaign—something these other rapid assess-
ment methods do not include. 
The consistent responses from the respondents in 
the evaluations provide for a positive evaluation 
of GAPS in each of the two settings it was applied. 
Based on the evaluation design, a positive evalua-
tion of two specific GAPS applications (and no nega-
tive evaluations) provide for an overall positive 
evaluation of the GAPS as a complementary meth-
od to help improve the quality of mass vaccination 
campaigns and for cross-checking or triangulating 
routinely-collected administrative estimates of vac-
cination coverage. This positive evaluation suggests 
that further applications of GAPS with concurrent 
evaluation studies should be carried out to confirm 
Table 2. Results of evaluation of GAPS, Nepal, February 2004
Name of campaign 2004 Nepal NID 2nd Round (February)
No. of evaluation sites 3
No. passed/no. failed 3  /  0
Campaign organizer/respondent 1 2 3 4
Summary
calculations
Level of responsibility District District National National
Type of organization  Government NGO Government UN/WHO
State that GAPS is useful for 
confirming the effectiveness of 
campaign planning and imple-
mentation
(or state that GAPS is useful 
for comparing with routine 
information collected during 
campaigns)
Yes Yes Yes Yes Yes–4
No–0
State that they recommend (or 
have already decided) contin-
uing campaign strategies
Yes Yes Yes Yes Yes–4
No–0
State that carrying out GAPS was 
worth the effort
Yes Yes Yes Yes Yes–4
No–0
Most frequently-mentioned 
negative things about GAPS
  
No. Idea Frequency
1
Not all potentially-problematic sites 
can be evaluated 2
Most frequently-mentioned 
ideas for making the evalua-
tion more useful or practical
1 Adapt GAPS and LQAS for other uses 2
2
Visit potential problem sites that 
were never visited before (overcome 
any possible ‘Hawthorne’ effect)
1
GAPS=Geographic assessment of planning and services; LQAS=Lot quality assurance sampling; 
NID=National Immunization Day; UN=United Nations; WHO=World Health OrganizationWeiss WM et al. Use of GAPS in improving quality of mass immunization campaigns
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the findings here and to examine the usefulness of 
GAPS in other settings.
Limitations of evaluation
The outcome of any single application of GAPS 
is not predictable. While we applied GAPS in two 
very different settings (Ethiopia and Nepal), the 
outcomes were very similar: no sites evaluated in 
the post-campaign phase had many unvaccinated 
children. We did not evaluate an application of 
GAPS in the situation where one or more sites had 
many unvaccinated children during the post-cam-
paign phase. This is one limitation of the study. It 
is possible that expert opinions about GAPS would 
not be much positive in this second situation. We 
could have evaluated more applications of GAPS. 
However, adding more applications of GAPS to 
this evaluation study would not guarantee that we 
would be able to evaluate GAPS where one or more 
sites were identified as having a pocket of unvacci-
nated children. Because of this and because of time 
and resource constraints, we did not include more 
applications of GAPS in the evaluation study once 
two applications demonstrated positive results.  
Another limitation of this evaluation study was 
that there were a limited number of people who 
qualified for our expert interviews. We did not in-
terview a large representative sample of campaign 
organizers to quantify the proportion with positive 
statements about GAPS. Instead, we purposively 
sampled the small number of people who we con-
sidered relevant experts because of their experience 
in planning, implementing and evaluating vacci-
nation programmes; involvement in mass immu-
nization campaigns; and had participated in an 
application of GAPS in the field. We also selected 
experts with various perspectives: NGO, govern-
ment, UN, district and national levels. In any one 
setting, there were only a handful of persons who 
met these criteria, and we did not want to weigh 
one perspective heavily over others. For this reason, 
3-4 expert opinions about GAPS in each setting was 
considered to be appropriate.
Recommendations for improving the GAPS 
methodology 
A detailed description of the GAPS methodology is 
available from the author. Sites visited in the post-
campaign phase in both the applications were those 
sites that were considered most likely—among the 
other sites in the district—to have a pocket of unvac-
cinated children. The decisions about sites to visit 
in the post-campaign phase were based primari- 
ly on observations and feedback of health work-
ers during the campaign. Therefore, all sites visited 
in the post-campaign phase of both the applica-
tions had received some kind of supervision visit 
during the campaign. One recommendation we 
received during our expert interviews was to also 
include, during the post-campaign phase, a visit to 
a potential problem site that had received no or 
minimal supervision during the campaign. The 
purpose of this recommendation was to check 
a site where there was less a chance that perfor-
mance reflected a reaction to increased supervision 
attention during the campaign. Another recom-
mendation was to adapt the GAPS methodology, 
particularly the LQAS elements, for use in testing 
hypotheses about the quality of other aspects of 
vaccination programmes, such as the quality of 
documentation, the cold-chain and supplies, and 
vaccinator’s techniques. The methodology can 
be adapted to identify specific sites within a pro-
gramme area with performance significantly lower 
than expected.
Another potential improvement includes regular 
updating as we learn about additional factors that 
may predict the existence of geographic pockets of 
unvaccinated children. For example, an outbreak 
of wild polio in 12 polio-free countries occurred 
during the field-testing of this method as a result 
of stoppages in polio vaccination in several states 
in northern Nigeria. The stoppages occurred after 
political and traditional authorities in these limited 
geographic areas raised concerns about the safety of 
the oral polio vaccine. The potential of authorities 
stopping the campaign was not considered a factor 
that might predict a pocket of unvaccinated chil-
dren during the field-testing as this issue did not 
appear in the literature previously. This factor was 
included in updates of the GAPS method. 
An additional recommendation is to apply GAPS to 
other types of mass campaigns. For example, cur-
rently, there are campaigns taking place around the 
world for the measles vaccine, vitamin A supple-
ments, deworming medications, tetanus toxoid 
vaccine, insecticide-treated bednets, meningitis vac-
cine in emergencies, ivermectrin, and others. GAPS 
can be applied to these other types of campaigns 
after appropriate adaptation to both identify pock-
ets of persons missed by the campaign and provide 
a population-based source of data for confirming 
administrative estimates of coverage.
In summary, although this evaluation was limited 
in the number of applications evaluated, GAPS 
appears to have promise as a practical method to Weiss WM et al. Use of GAPS in improving quality of mass immunization campaigns
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help improve the quality of mass immunization 
campaigns in two main ways: (a) testing hypoth-
eses about pockets of unvaccinated persons and 
(b) providing a population-based source of data to 
help triangulate administrative estimates of cover-
age. Further applications in different settings will 
be needed to confirm these findings and/or under 
what circumstances GAPS might be used for com-
plementing the existing methods and procedures 
to improve mass immunization campaigns. GAPS 
may also be considered for improving other types 
of health campaigns, such as distribution of insec-
ticide-treated bednets, vitamin A capsules, and de-
worming medications.
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